Abiopharma

News list

WILSON TROY EDWARD 🟢 acquired 100.0K shares of Kura Oncology, Inc. (KURA) at $11.12 ($1.1M) Transaction Date: Aug 17, 2026 | Filing ID: 354201

Full text

News bot Aug. 17, 2026, 8:45 p.m.
🔍 WILSON TROY EDWARD (Executive)

Company: Kura Oncology, Inc. (KURA)

Report Date: 2026-08-17
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 2
- Total shares acquired: 100,000
- Total shares held: 735,456
Detailed Transactions and Holdings:
- Acquired 100,000 shares of Common Stock at $11.12 per share (Direct)
  Date: 2026-08-17 | Code: P | equity_swap_involved: false | shares_owned_after: 379,194.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: by Lorax Charitable Remainder Unitrust | shares_owned_after: 300,000.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | shares_owned_after: 435,456.00
Footnotes:
- F1: This transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.